-transparent.png){kind=logo}
The efficacy and tolerance of parenterally administered piperacillin were evaluated in 50 adult patients hospitalized with systemic and urinary tract infections. Dosage for 46 patients was 4 to 12 g daily and for 4 patients, 16 to 24 g daily; in each case divided doses were given every 4 to 6 h. The duration of treatment for most patients was 5 to 10 days. Of the 50 patients, 45 (90%) were considered cured, and 57 (89%) of the 64 pathogens isolated were eradicated by piperacillin treatment. Side effects, reported by 12 patients, were mild to moderate in degree and consisted of vein irritation, thrombophlebitis, pain at the injection site, and diarrhea, Piperacillin appears to be a highly effective antibiotic for treating infections caused by susceptible gram-positive and gram-negative microorganisms.
B Lutz, and
W Mogabgab, and
B Holmes, and
B Pollock, and
R Beville
January 1988,
Archivio Monaldi per le malattie del torace,
B Lutz, and
W Mogabgab, and
B Holmes, and
B Pollock, and
R Beville
March 2008,
Expert opinion on drug metabolism & toxicology,
B Lutz, and
W Mogabgab, and
B Holmes, and
B Pollock, and
R Beville
January 1984,
Giornale italiano di chemioterapia,
B Lutz, and
W Mogabgab, and
B Holmes, and
B Pollock, and
R Beville
August 2007,
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
B Lutz, and
W Mogabgab, and
B Holmes, and
B Pollock, and
R Beville
January 1980,
Chemotherapy,
B Lutz, and
W Mogabgab, and
B Holmes, and
B Pollock, and
R Beville
July 1989,
Journal of chemotherapy (Florence, Italy),
B Lutz, and
W Mogabgab, and
B Holmes, and
B Pollock, and
R Beville
January 1986,
Minerva stomatologica,
B Lutz, and
W Mogabgab, and
B Holmes, and
B Pollock, and
R Beville
September 1996,
Panminerva medica,
B Lutz, and
W Mogabgab, and
B Holmes, and
B Pollock, and
R Beville
January 2004,
Clinical therapeutics,
B Lutz, and
W Mogabgab, and
B Holmes, and
B Pollock, and
R Beville
January 1991,
Minerva psichiatrica,
